# Matrix Metalloproteinases Neutralizing Agents in Oral Lichen Planus

> **NCT04336488** · EARLY_PHASE1 · UNKNOWN · sponsor: **Jaylane kadry Ghonima** · enrollment: 40 (estimated)

## Conditions studied

- Oral Lichen Planus

## Interventions

- **DRUG:** Matrix Metalloproteinase Inhibitors (Orochem)
- **DRUG:** Kenacort A,

## Key facts

- **NCT ID:** NCT04336488
- **Lead sponsor:** Jaylane kadry Ghonima
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-07-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04336488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04336488, "Matrix Metalloproteinases Neutralizing Agents in Oral Lichen Planus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04336488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*